Protagonist Therapeutics, Inc. (PTGX) key performance indicators and operating metrics (4 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Psoriasis Area and Severity Index at least 90 percent improvement at Week 24 (Icotrokinra) | 65.00 percent | FY2025-Q1 |
| Psoriasis Area and Severity Index at least 90 percent improvement at Week 16 (Icotrokinra) | 50.00 percent | FY2025-Q1 |
| Investigator's Global Assessment score 0 or 1 at Week 24 (Icotrokinra) | 74.00 percent | FY2025-Q1 |
| Icotrokinra milestone payments earned | 165M | FY2024-Q4 |
Back to PTGX overview · PTGX earnings · PTGX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.